Ticker Symbol: PNT

POINT Biopharma Global Inc

$9.02 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001811764

Company Profile

POINT Biopharma Global Inc. is a globally focused radiopharmaceutical company building a platform for the clinical development and commercialization of radioligands that fight cancer. POINT Biopharma Global Inc. is combining a portfolio of best-in-class radiopharmaceutical assets, a seasoned management team, expertise in radioisotopes such as Actinium-225 (Ac-225) and Lutetium-177 (Lu-177), and industry-leading manufacturing capabilities and supply chain to revolutionize theragnostic drug development and radioligand commercialization.

Sector: Manufacturing

Industry: Pharmaceutical Preparation Manufacturing

Standard Industrial Classification Code (SIC code): 2834

Address: N/A

Website: www.pointbiopharma.com

CEO: N/A

Tags: N/A

Pricing

Last Updated: October 3, 2023 03:00 PM EST

Previous Close: $12.36

Change: $5.67 ( 84.89%)

Days Range: $12.27 - $12.41

Beta: 0.68

52wk. High: $13.03

52wk. Low: $5.59

Ytd. Change 76.59%

50 Day Moving Average: $9.32

200 Day Moving Average: $8.93

Shares Outstanding: 105765954

Valuation

Market Cap: 130.7B

PE Ratio: 13.19

EPS (TTM): 0.9373

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A